Development of a virosomal malaria vaccine candidate: from synthetic peptide design to clinical concept validation

ISSN： 1746-0794

Source： Future Virology, Vol.7, Iss.8, 2012-08, pp. : 779-790

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virosomal technology in malaria vaccine development

By Pluschke Gerd Tamborrini Marco

Future Virology, Vol. 5, Iss. 3, 2010-05 ,pp. : 247-250

Future Medicine

Access to resources Recommend Favorite

Sagopilone (ZK-EPO): from a natural product to a fully synthetic clinical development candidate

By Klar Ulrich Hoffmann Jens Giurescu Marius

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1735-1748

Informa Healthcare

Access to resources Recommend Favorite

Progress in development of a malaria vaccine

Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Incentives for malaria vaccine development?

Inpharma, Vol. 1, Iss. 1233, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Development of influenza virosome-based synthetic malaria vaccines

By Daubenberger Claudia A Pluschke Gerd Zurbriggen Rinaldo Westerfeld Nicole

Expert Opinion on Drug Discovery, Vol. 3, Iss. 4, 2008-04 ,pp. : 415-423

Informa Healthcare

Access to resources Recommend Favorite